(Q30432746)

16 October 2017

Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study (English)

1 reference

16 October 2017

1 reference

18

0 references

Lene Mellemkjaer

12

0 references

Patrick Concannon

22

0 references

Anne-Lise Børresen-Dale

13

Anne-Lise Borresen-Dale

0 references

Anne Reiner

Anne S Reiner

19

0 references

Roy E Shore

Roy E Shore

5

0 references

Leslie Bernstein

8

Leslie Bernstein

1 reference

16 October 2017

11

Kathleen E Malone

1 reference

16 October 2017

3

Marilyn Stovall

1 reference

16 October 2017

6

Bryan Langholz

1 reference

16 October 2017

1

Jonine L Bernstein

1 reference

16 October 2017

4

John D Boice

1 reference

16 October 2017

14

Barry S Rosenstein

1 reference

16 October 2017

15

Sharon N Teraoka

1 reference

WECARE Study Collaborative Group

16 October 2017

23

WECARE Study Collaborative Group

1 reference

16 October 2017

Robert W Haile

2

1 reference

16 October 2017

Duncan C Thomas

7

1 reference

16 October 2017

Charles F Lynch

9

1 reference

16 October 2017

Jorgen H Olsen

10

1 reference

16 October 2017

Anh T Diep

16

1 reference

16 October 2017

Susan A Smith

17

1 reference

16 October 2017

Xiaolin Liang

20

1 reference

16 October 2017

Richard A Gatti

21

1 reference

16 October 2017

language of work or name

English

0 references

publication date

19 March 2010

1 reference

Journal of the National Cancer Institute

16 October 2017

1 reference

16 October 2017

102

1 reference

16 October 2017

7

1 reference

16 October 2017

475-483

1 reference

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Variants in the ATM gene associated with a reduced risk of contralateral breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Statistical methods for analysis of radiation effects with tumor and dose location-specific information with application to the WECARE study of asynchronous contralateral breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Variation of breast cancer risk among BRCA1/2 carriers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Cancer risks and mortality in heterozygous ATM mutation carriers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Radiation effects on breast cancer risk: a pooled analysis of eight cohorts

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Dominant Negative ATM Mutations in Breast Cancer Families

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Predicting deleterious amino acid substitutions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Prediction of deleterious human alleles

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Application of the missing-indicator method in matched case-control studies with incomplete data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Heterozygous ATM mutations do not contribute to early onset of breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Breast and other cancers in families with ataxia-telangiectasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Mortality and cancer incidence in 263 patients with ataxia-telangiectasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

The genetic epidemiology of second primary breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Malignant neoplasms in the families of patients with ataxia-telangiectasia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Reproductive history and risk of second primary breast cancer: the WECARE study

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Designing and implementing quality control for multi-center screening of mutations in the ATM gene among women with breast cancer.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2902825

Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations

26 November 2018

1 reference

12 December 2020

Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study

1 reference

12 December 2020

BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients

1 reference

12 December 2020

Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity

1 reference

12 December 2020

Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain

1 reference

12 December 2020

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

12 December 2020

Cancer in the contralateral breast after radiotherapy for breast cancer

1 reference

12 December 2020

Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer

1 reference

12 December 2020

Cancer risk according to type and location of ATM mutation in ataxia-telangiectasia families

1 reference

12 December 2020

Risks for familial and contralateral breast cancer interact multiplicatively and cause a high risk

1 reference

12 December 2020

Design considerations for genomic association studies: importance of gene-environment interactions

1 reference

12 December 2020

Second primary in the contralateral breast after treatment of breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJQ055

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

20305132

1 reference